Gnomestar Craft Inc
Gnomestar Craft Inc. engages in the production and distribution of cannabis product for medical and recreational use in Canada. The company was formerly known as Vodis Pharmaceuticals Inc. and changed its name to Gnomestar Craft Inc. in December 2020. Gnomestar Craft Inc. was incorporated in 2011 and is based in Delta, Canada.
Gnomestar Craft Inc (VDQSF) - Net Assets
Latest net assets as of December 2021: $-2.11 Million USD
Based on the latest financial reports, Gnomestar Craft Inc (VDQSF) has net assets worth $-2.11 Million USD as of December 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.12 Million) and total liabilities ($3.23 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.11 Million |
| % of Total Assets | -188.36% |
| Annual Growth Rate | N/A |
| 5-Year Change | -285.71% |
| 10-Year Change | N/A |
| Growth Volatility | 161.73 |
Gnomestar Craft Inc - Net Assets Trend (2012–2021)
This chart illustrates how Gnomestar Craft Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Gnomestar Craft Inc (2012–2021)
The table below shows the annual net assets of Gnomestar Craft Inc from 2012 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-03-31 | $-1.65 Million | -16.80% |
| 2020-03-31 | $-1.41 Million | -43.07% |
| 2019-03-31 | $-987.69K | -242.98% |
| 2018-03-31 | $690.80K | -22.27% |
| 2017-03-31 | $888.70K | +134.13% |
| 2016-03-31 | $379.58K | -37.20% |
| 2015-03-31 | $604.40K | +18.72% |
| 2014-03-31 | $509.11K | +324.34% |
| 2013-03-31 | $119.98K | -36.78% |
| 2012-03-31 | $189.78K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Gnomestar Craft Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1837780300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $13.84 Million | % |
| Other Comprehensive Income | $-38.46K | % |
| Other Components | $3.01 Million | % |
| Total Equity | $-1.65 Million | 100.00% |
Gnomestar Craft Inc Competitors by Market Cap
The table below lists competitors of Gnomestar Craft Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PARAGON GROUP
BE:46P1
|
$90.65K |
|
UESTRA
BE:HVB
|
$90.66K |
|
NOKIAN TYRES - Dusseldorf Stock Exchang
DU:NRE
|
$90.67K |
|
GMEXICO-B (4GE.SG)
STU:4GE
|
$90.69K |
|
DWS Municipal Income Trust
NYSE:KTF
|
$90.57K |
|
United Corporations Limited
TO:UNC
|
$90.42K |
|
Aquarius AI Inc
PINK:GOOLF
|
$90.29K |
|
Hays plc
LSE:HAS
|
$90.26K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Gnomestar Craft Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from -1,413,101 to -1,650,438, a change of -237,337.
- Net loss of 875,562 reduced equity.
- Other comprehensive income increased equity by 107,698.
- Other factors increased equity by 530,527.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-875.56K | -53.05% |
| Other Comprehensive Income | $107.70K | +6.53% |
| Other Changes | $530.53K | +32.14% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Gnomestar Craft Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-03-31 | $0.51 | $0.00 | x |
| 2013-03-31 | $0.09 | $0.00 | x |
| 2014-03-31 | $0.27 | $0.00 | x |
| 2015-03-31 | $0.06 | $0.00 | x |
| 2016-03-31 | $0.02 | $0.00 | x |
| 2017-03-31 | $0.04 | $0.00 | x |
| 2018-03-31 | $0.02 | $0.00 | x |
| 2019-03-31 | $-0.02 | $0.00 | x |
| 2020-03-31 | $-0.02 | $0.00 | x |
| 2021-03-31 | $-0.02 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Gnomestar Craft Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -328.54%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-238.24%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | -44.64% | 0.00% | 0.00x | 1.06x | $-103.70K |
| 2013 | -65.76% | 0.00% | 0.00x | 1.17x | $-90.89K |
| 2014 | -35.60% | 0.00% | 0.00x | 1.10x | $-232.17K |
| 2015 | -344.81% | 0.00% | 0.00x | 1.75x | $-2.14 Million |
| 2016 | -653.46% | -3000.71% | 0.03x | 8.07x | $-2.52 Million |
| 2017 | -696.12% | -59749.21% | 0.00x | 4.17x | $-6.28 Million |
| 2018 | -541.98% | 0.00% | 0.00x | 5.78x | $-3.81 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.11 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.16 Million |
| 2021 | 0.00% | -328.54% | 0.22x | 0.00x | $-710.52K |
Industry Comparison
This section compares Gnomestar Craft Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $580,491,146
- Average return on equity (ROE) among peers: -45.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Gnomestar Craft Inc (VDQSF) | $-2.11 Million | -44.64% | N/A | $90.63K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $14.78 Million | -64.19% | 0.99x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-241.47K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -329.21% | 0.78x | $194.64 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $37.06 Million | 39.05% | 0.16x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $32.70 Million | -18.88% | 0.16x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.84 |
| Adcock Ingram Holdings Limited (AIHLF) | $4.54 Billion | 14.90% | 0.58x | $85.61 Million |